DARMSTADT, Germany and
PARIS, April 17, 2014 /PRNewswire/ --
Merck Serono, the biopharmaceutical division of Merck, announced
today that Belén Garijo, President & Chief Executive Officer of
Merck Serono, has been appointed as an independent Director of
L'Oréal for a period of four years. The appointment of Belén Garijo
as a new member of the Board of Directors of L'Oréal was approved
by shareholders at the Company's 2014 Annual General Meeting held
today in Paris.
Belén Garijo is a medical doctor, specialized in clinical
pharmacology and internal medicine. She joined Merck Serono in
2011. During her 25-year career in the pharmaceutical industry, she
has held diverse senior functions in a number of countries. She
worked in research for eight years, before moving to commercial
functions of increasing responsibility. Before joining the
pharmaceutical industry, she worked for six years as a practicing
physician.
About Merck Serono
Merck Serono is the biopharmaceutical division of Merck. With
headquarters in Darmstadt, Germany, Merck Serono offers leading brands in
150 countries to help patients with cancer, multiple sclerosis,
infertility, endocrine and metabolic disorders as well as
cardiovascular diseases. In the United
States and Canada, EMD
Serono operates as a separately incorporated subsidiary of Merck
Serono.
Merck Serono discovers, develops, manufactures and markets
prescription medicines of both chemical and biological origin in
specialist indications. We have an enduring commitment to deliver
novel therapies in our core focus areas of neurology, oncology,
immuno-oncology and immunology.
For more information, please visit
http://www.merckserono.com.
All Merck Press Releases are distributed by e-mail at the same
time they become available on the Merck Website. Please go to
http://www.merckgroup.com/subscribe to register online, change your
selection or discontinue this service.
Merck is a leading company for innovative and top-quality
high-tech products in the pharmaceutical and chemical sectors. With
its four divisions Merck Serono, Consumer Health, Performance
Materials and Merck Millipore, Merck generated total revenues of
€ 11.1 billion in 2013. Around 38,000 Merck employees work in
66 countries to improve the quality of life for patients, to
further the success of customers and to help meet global
challenges. Merck is the world's oldest pharmaceutical and chemical
company - since 1668, the company has stood for innovation,
business success and responsible entrepreneurship. Holding an
approximately 70 percent interest, the founding family remains the
majority owner of the company to this day. Merck, Darmstadt,
Germany is holding the global
rights to the Merck name and brand. The only exceptions are
Canada and the United States, where the company is known
as EMD.
Contact:
Bénédicte Bogh
benedicte.bogh@merckgroup.com
SOURCE Merck Serono